| Literature DB >> 35804519 |
María Bernad-Roche1, Alejandro Casanova-Higes1, Clara María Marín-Alcalá2, Raúl Carlos Mainar-Jaime1.
Abstract
Pigs shedding Salmonella at slaughter are considered a source of carcass contamination and human infection. To assess this potential risk, the proportion of Salmonella shedders that arrive for slaughter was evaluated in a population of 1068 pigs from 24 farms. Shedding was present in 27.3% of the pigs, and the monophasic variant of Salmonella Typhimurium, an emerging zoonotic serotype, was the most prevalent (46.9%). Antimicrobial resistance (AMR) in Salmonella isolates was common, but few isolates showed AMR to antimicrobials of critical importance for humans such as third-generation cephalosporins (5%), colistin (0%), or carbapenems (0%). However, AMR to tigecycline was moderately high (15%). The efficacy of an esterified formic acid in the lairage drinking water (3 kg formic acid/1000 L) was also assessed as a potential abattoir-based strategy to reduce Salmonella shedding. It was able to reduce the proportion of shedders (60.7% in the control group (CG) vs. 44.3% in the treatment group (TG); p < 0.01). After considering clustering and confounding factors, the odds of shedding Salmonella in the CG were 2.75 (95% CI = 1.80-4.21) times higher than those of the TG, suggesting a potential efficacy of reduction in shedding as high as 63.6%. This strategy may contribute to mitigating the burden of abattoir environmental contamination.Entities:
Keywords: Salmonella; abattoir; drinking water; formic acid; shedding; swine
Year: 2022 PMID: 35804519 PMCID: PMC9264893 DOI: 10.3390/ani12131620
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 3.231
Prevalence of Salmonella shedding and major serotypes found in slaughter pigs from 24 farms.
| Farm ID | N | No. + (%) | Serotypes Involved (No. of Strains) |
|---|---|---|---|
| 1 | 43 | 0 (0.00) | - |
| 2 | 46 | 19 (41.30) | |
| 3 | 45 | 1 (2.22) | other (1) |
| 4 | 49 | 9 (18.37) | |
| 5 | 46 | 35 (76.09) | |
| 6 | 48 | 27 (56.25) | |
| 7 | 25 | 18 (72.00) | other (18) |
| 8 | 48 | 33 (68.75) | |
| 9 | 46 | 15 (32.61) | |
| 10 | 45 | 39 (86.67) | |
| 11 | 50 | 4 (8.00) | mST (2), other (2) |
| 12 | 51 | 1 (1.96) | |
| 13 | 44 | 8 (18.18) | mST (8) |
| 14 | 48 | 9 (18.75) | other (9) |
| 15 | 48 | 7 (14.58) | mST (7) |
| 16 | 47 | 5 (11.36) | other (5) |
| 17 | 46 | 4 (8.70) | other (4) |
| 18 | 39 | 1 (2.56) | other (1) |
| 19 | 34 | 27 (79.41) | mST (25), other (2) |
| 20 | 46 | 1 (2.17) | other (1) |
| 21 | 44 | 2 (4.55) | |
| 22 | 44 | 19 (43.18) | |
| 23 | 44 | 0 (0.00) | - |
| 24 | 42 | 8 (19.05) | |
| All | 1068 | 292 (27.34) |
mST: monophasic variant of S. Typhimurium; “other”: serotypes other than S. Typhimurium and its monophasic variant.
Occurrence of resistance to critically important antimicrobials in Salmonella isolates from pigs.
| Antimicrobial Class | Antimicrobial Agent * | No. ST (%) | No. mST (%) | No. “Other” Serotypes (%) | Farm ID |
|---|---|---|---|---|---|
| Penicillins | AMP | 14 (70.0) | 26 (92.9) | 19 (59.4) | 2, 4, 5, 6, 8, 9, 10, 11, 12, 13, 15, 16, 17, 19, 20, 21, 22, 24 |
| AMC | 0 (0.0) | 3 (10.7) | 3 (9.4) | 11, 13 | |
| TZP | 0 (0.0) | 2 (7.1) | 0 (0.0) | 11 | |
| Cephalosporins | CXM | 1 (5.0) | 1 (3.6) | 3 (9.4) | 13, 22 |
| FOX | 0 (0.0) | 0 (0.0) | 0 (0.0) | - | |
| CTX | 0 (0.0) | 1 (3.6) | 3 (9.4) | 13, 22 | |
| CAZ | 0 (0.0) | 0 (0.0) | 3 (9.4) | 22 | |
| FEP | 0 (0.0) | 0 (0.0) | 0 (0.0) | - | |
| Carbapenems | ETP | 0 (0.0) | 0 (0.0) | 0 (0.0) | - |
| IPM | 0 (0.0) | 0 (0.0) | 0 (0.0) | - | |
| Polymyxins | CST | 0 (0.0) | 0 (0.0) | 0 (0.0) | - |
| Aminoglycosides | AMK | 0 (0.0) | 0 (0.0) | 0 (0.0) | - |
| GEN | 0 (0.0) | 3 (10.7) | 2 (6.3) | 8, 11, 13 | |
| Tetracyclines | TGC | 4 (20.0) | 4 (14.3) | 4 (12.5) | 2, 11, 16, 17, 22 |
| Quinolones | NAL | 2 (10.0) | 7 (25.0) | 7 (21.9) | 8, 9, 11, 12, 13, 16, 19, 20, 22, 24 |
| CIP | 0 (0.0) | 0 (0.0) | 1 (3.1) | 16 | |
| Sulphonamides dihydrofolate reductase inhibitors | SXT | 2 (10.0) | 3 (10.7) | 11 (34.4) | 8, 9, 11, 12, 13, 16, 17, 19 |
ST: Salmonella Typhimurium; mST: monophasic variant of S. Typhimurium. * Ampicillin (AMP), amoxicillin-clavulanic acid (AMC), piperacillin-tazobactam (TZP), cefuroxime (CXM), cefoxitin (FOX), cefotaxime (CTX), ceftazidime (CAZ), cefepime (FEP), ertapenem (ETP), imipenem (IPM), colistin (CST), amikacin (AMK), gentamicin (GEN), tigecycline (TGC), nalidixic acid (NAL), ciprofloxacin (CIP), trimethoprim-sulfamethoxazole (SXT).
Figure 1Proportion of Salmonella shedding at slaughter in the seven trials and globally. Significant differences between the control (CG) and the treated group (TG) are indicated (** p < 0.05; *** p < 0.01; Fisher´s exact test).
Number of pigs shedding Salmonella and estimated water consumption per pig.
| Estimated Water Consumption Per Pig | ||||
|---|---|---|---|---|
| <0.9 L | ≥0.9 L * | |||
| No. (%) | No. (%) | Total | ||
| Yes | 96 (76.8) | 29 (23.2) | 125 | |
| No | 66 (42.0) | 91 (58.0) | 157 | |
| OR = 4.56 (95% CI: 2.70–7.69; | ||||
* Categories based on the median of the estimated mean water consumption per pig.
Results of the random-effects logistic regression analysis to assess the relationship between water treatment with the esterified formic acid and Salmonella shedding after adjusting by season and time at lairage.
| Logistic Regression Parameters | |||||||
|---|---|---|---|---|---|---|---|
| Variable | N | No. + (%) | β | SE (β) |
| OR | 95% CI OR |
| Group | |||||||
| Treatment 1 | 282 | 125 (44.3) | 1 | ||||
| Control | 280 | 170 (60.7) | 1.01 | 0.21 | <0.001 | 2.75 | 1.80–4.21 |
| Season | |||||||
| Spring 1 | 240 | 156 (65) | 1 | ||||
| Summer | 80 | 31 (38.7) | −3.32 | 2.06 | 0.107 | 0.036 | 0.0006–2.05 |
| Autumn | 242 | 108 (44.6) | −2.45 | 1.42 | 0.085 | 0.086 | 0.005–1.39 |
| Lairage time | |||||||
| <15 h | 320 | 171 (53.4) | |||||
| ≥15 h | 242 | 124 (51.2) | 1.94 | 1.50 | 0.195 | 7.01 | 0.36–132 |
1 Reference categories. Trial (random variable): variance 1.422; intra class correlation (ICC): 0.30 (95% CI: 0.12–0.56).